References
- Phillips TJ, Dover JS. Leg ulcers. J Am Acad Dermatol 1991; 25(6 Pt 1): 965–87
- Caputo GM, Cavanagh PR, Ulbrecht JS, et al. Assessment and management of foot disease in patients with diabetes. N Engl J Med 1994; 331 (13): 854–60
- Darke SG, Penfold C. Venous ulceration and saphenous ligation. Eur J Vase Surg 1992; 6(1): 4–9
- Steed DL, Donohoe D, Webster MW, et al, for the Diabetic Ulcer Study Group. Effect of extensive debridement and treatment on the healing of diabetic foot ulcers. J Am Coll Surg 1996; 183(1): 61–4
- Wieman TJ, Smiell JM, Su Y. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers: a phase III randomized placebo-controlled double-blind study. Diabetes Care 1998; 21(5): 822–7
- Falanga V, Margolis D, Alvarez O, et al, for the Human Skin Equivalent Investigators Group. Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Arch Dermatol 1998; 134(3): 293–300